Oral Health Parameter-Based Diabetes Type 2 Indication Using Machine Learning

NCT ID: NCT06981286

Last Updated: 2025-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-30

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to explore the potential of using machine learning (ML) algorithms to predict Diabetes type2, based on oral health and demographic data. The objective is to evaluate the effectiveness of various ML models and identify the most relevant oral health indicators for predicting type 2 diabetes in individuals with mild cognitive impairment aged 60 and above.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This cross-sectional study utilizes oral health and demographic data from the Swedish National Study on Aging and Care (SNAC-B). Participants aged 60 years or older with Mild Cognitive Impairment will be included in the analysis. The data will be used to develop and evaluate machine learning models for predicting type 2 diabetes.

Objectives:

1. Primary Objective: To assess the potential of oral health parameters for binary classification of type 2 diabetes or not.
2. Secondary Objective: To identify the most influential oral health parameters contributing to type 2 diabetes predictions.
3. Tertiary Objective: To compare the performance of Random Forest (RF), Support Vector Machine (SVM), and CatBoost (CB) classifiers in predicting type 2 diabetes using oral health data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

T2D

Older individuals with Diabetes type 2

A dataset comprising participants withT2D will be used to evaluate the classification performance of various machine learning techniques.

Intervention Type OTHER

A dataset comprising participants with T2D will be used to evaluate the classification performance of various machine-learning techniques.

Group/Cohort Description: Older individuals without Diabetes type 2

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A dataset comprising participants withT2D will be used to evaluate the classification performance of various machine learning techniques.

A dataset comprising participants with T2D will be used to evaluate the classification performance of various machine-learning techniques.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals aged 60 years or older.
* Participants with recorded oral health parameters with or without Diabetes type2

Exclusion Criteria

• Individuals with Diabetes type1
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Blekinge Institute of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Health, Blekinge Institute of Technology

Karlskrona, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Johan Flyborg, DDS, PhD

Role: CONTACT

+46707283117

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Johan Flyborg

Role: primary

0707283117

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DT2 prediction

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Health and Lifestyle Tool
NCT04691973 ACTIVE_NOT_RECRUITING
Prevention With the Health and Lifestyle Tool
NCT05006508 ACTIVE_NOT_RECRUITING NA
MoKaRi II Intervention Study
NCT05382533 COMPLETED NA